comparemela.com

Latest Breaking News On - Shield therapeutics - Page 12 : comparemela.com

Shield Therapeutics raises funds to accelerate commercial opportunity for Accrufer iron deficiency treatment in US market

Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) is raising up to US$27.5 million of new funds to support its development of Accrufer, its iron deficiency.

Shield Therapeutics : Launch Announcement -September 28, 2023 at 09:18 am EDT

Please read and confirm that you accept the following terms and conditions IMPORTANT INFORMATION ELECTRONIC VERSIONS OF THE MATERIALS YOU.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.